CD8A and neoplasm: Based on the role they may play in tumor progression, immunosuppression of activated CD8+ T cells, or in promoting drug resistance between cancer cells by horizontal transfer of miRNAs regulating resistance to chemotherapeutics, it is reasonable to attempt to inhibit their release from tumor cells or even eliminate them from peripheral blood.